Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients. Meeting Abstract

cited authors

  • Le, Xiuning; Goldman, Jonathan Wade; Clarke, Jeffrey Melson; Tchekmedyian, Nishan; Piotrowska, Zofia; Chu, David; Bhat, Gajanan; Lebel, Francois M.; Socinski, Mark A.

authors

Publication Date

  • May 20, 2020

webpage

published in

category

volume

  • 38

issue

  • 15